InfuSystem Holdings Inc. in Rochester Hills and Sanara MedTech Inc. are partnering to form SI Wound Care to deliver a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction.
“Over the past few years, we have built our NPWT (negative pressure wound therapy) business as a turnkey solution with a focus on offering high quality options to patients and providers,” says Richard Dilorio, CEO of InfuSystem.
“We believe the wound care market represents a significant opportunity to drive revenue growth for our integrated therapy services (“TS) platform by treating both chronic and acute wounds. Partnering with Sanara enables us to better serve patients and care providers nationally by offering a complete line of advanced wound care products.”
The partnership is expected to enable InfuSystem to offer products including Cork Medical’s negative pressure wound therapy (NPWT) devices and supplies and Sanara’s advanced wound care product line to new customers through the jointly controlled entity.
Each partner brings a differentiated and complementary offering to the companies’ combined solution.
The Sanara team has significant wound care expertise in the acute care setting as well as throughout the entire continuum of care. Sanara currently employs sales managers with deep industry experience across the U.S. Sanara says its portfolio of wound care products is complementary to NPWT services and can be used before, during, or after NPWT to remove microbes from the wound bed and promote healing.
InfuSystem is a participating in-network provider for more than 770 health insurance networks covering over 95 percent of the U.S. population and has seven distribution centers across North America.
InfuSystem can leverage this infrastructure to gain acceptance for the new products and services. Additionally, InfuSystem is a distributor of Cork NPWT devices and supplies in the U.S. and Canada. The partnership is expected to enable InfuSystem to offer new products and thereby reach new NPWT business throughout the continuum of care, from the hospital to the home.
“NPWT is a key technology offering in the wound care market that has benefited millions of wound care patients,” says Zach Flemming, CEO of Sanara. “By pairing Sanara’s product line and deep expertise in wound care with InfuSystem’s existing NPWT business, including sales, distribution, clinical support, and revenue cycle capabilities, we hope to offer a compelling solution to a broader patient universe; offering significant value and improved outcomes for patients, providers, and payers.”